ROSEMARY MAZANET, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

ABEONA THERAPEUTICS INC.

Filing Date	Source Excerpt
2007-04-13	Rosemary Mazanet, M.D. serves as Chief Executive Officer of Breakthrough Therapeutics, LLC, a privately held development stage biotechnology company. ... Dr. Mazanet also serves as an independent director at GTx, Inc (Nasdaq: GTXI), Aksys, Ltd. and is a trustee at the University of Pennsylvania, School of Medicine. ... The table below represents the compensation paid to our directors during the year ended December 31, 2006: Rosemary Mazanet, MD, PhD: Fees earned or Paid in Cash ($) -, Option Awards ($) -, Total ($) -.
2008-04-22	Rosemary Mazanet, M.D. became a director of the Company in May 2006. ... Director Compensation Table - 2007: Rosemary Mazanet total compensation $371,000.

Filing Date

Source Excerpt

2007-04-13

Rosemary Mazanet, M.D. serves as Chief Executive Officer of Breakthrough Therapeutics, LLC, a privately held development stage biotechnology company. ... Dr. Mazanet also serves as an independent director at GTx, Inc (Nasdaq: GTXI), Aksys, Ltd. and is a trustee at the University of Pennsylvania, School of Medicine. ... The table below represents the compensation paid to our directors during the year ended December 31, 2006: Rosemary Mazanet, MD, PhD: Fees earned or Paid in Cash ($) -, Option Awards ($) -, Total ($) -.

2008-04-22

Rosemary Mazanet, M.D. became a director of the Company in May 2006. ... Director Compensation Table - 2007: Rosemary Mazanet total compensation $371,000.

Data sourced from SEC filings. Last updated: 2025-08-30